Allmed Solutions Ltd (TLV:ALMD)

Allmed Solutions Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.2	4.14	3.91	6.68	21.03	15.61
Short-Term Investments	20.11	25.25	39.27	50.43	-	-
Cash & Short-Term Investments	24.31	29.39	43.18	57.1	21.03	15.61
Cash Growth	-32.47%	-31.94%	-24.39%	171.50%	34.77%	57.02%
Other Receivables	0.99	0.78	0.33	0.55	0.96	0.25
Receivables	0.99	0.78	0.33	0.55	0.96	0.25
Prepaid Expenses	-	0.2	0.24	0.14	0.11	0.05
Other Current Assets	-	0.02	0.05	0.05	2.72	0.1
Total Current Assets	25.3	30.39	43.8	57.84	24.82	16.01
Property, Plant & Equipment	1.01	1.15	0.99	1.27	1.12	0.46
Long-Term Investments	-	-	-	-	6.7	9.41
Other Intangible Assets	-	-	0.01	0.06	0.12	0.17
Other Long-Term Assets	-	-	-	-	25.02	28.74
Total Assets	26.32	31.54	44.79	59.17	57.77	54.8

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.33	0.79	0.56	0.66	0.74	0.23
Accrued Expenses	-	1.77	1.58	1.55	2.06	1.68
Current Portion of Leases	0.33	0.36	0.38	0.33	0.2	0.3
Other Current Liabilities	1.68	0.03	0.01	0.11	0.2	0.07
Total Current Liabilities	2.34	2.95	2.54	2.65	3.19	2.27
Long-Term Leases	0.46	0.53	0.24	0.54	0.47	0.06
Other Long-Term Liabilities	-	-	-	-	0.15	0.15
Total Liabilities	2.8	3.48	2.78	3.2	3.81	2.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	20.25	19.22	19.22	21.7	21.62	16.16
Additional Paid-In Capital	249.05	247.82	243.88	244.5	243.56	235.68
Retained Earnings	-256.85	-250.22	-236.09	-227.34	-228.76	-216.63
Comprehensive Income & Other	8.21	8.43	12.31	14.57	15.11	15.19
Total Common Equity	20.66	25.25	39.31	53.42	51.52	50.41
Minority Interest	2.85	2.82	2.71	2.55	2.44	1.91
Shareholders' Equity	23.52	28.07	42.02	55.97	53.96	52.31
Total Liabilities & Equity	26.32	31.54	44.79	59.17	57.77	54.8

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.79	0.89	0.62	0.88	0.67	0.36
Net Cash (Debt)	23.52	28.5	42.56	56.23	20.36	15.25
Net Cash Growth	-33.74%	-33.03%	-24.31%	176.10%	33.53%	96.10%
Net Cash Per Share	0.25	0.30	0.43	0.52	0.23	0.19
Filing Date Shares Outstanding	94.69	100.02	96.1	108.49	108.11	80.82
Total Common Shares Outstanding	94.69	96.1	96.1	108.49	108.11	80.82
Working Capital	22.96	27.44	41.26	55.18	21.63	13.74
Book Value Per Share	0.22	0.26	0.41	0.49	0.48	0.62
Tangible Book Value	20.66	25.25	39.3	53.36	51.4	50.24
Tangible Book Value Per Share	0.22	0.26	0.41	0.49	0.48	0.62
Machinery	-	1.76	1.72	1.6	1.48	1.05

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 23, 2026

Data Sources Report a data error